Can-Fite’s Namodenoson to Enter NAFLD/NASH Phase 2 Clinical Trial
Can-Fite BioPharma has concluded preparations for its Phase 2 trial evaluating namodenoson (CF102) for the treatment of non-alcoholic fatty liver disease (NAFLD). The study will…
Liver cancer
Singapore Researchers Develop Probe That Improves Liver Cancer MRI Imaging
Researchers at the National University of Singapore have developed a probe that provides doctors with clearer and more accurate magnetic resonance images of liver cancer.
Hepko-V5 Cancer Vaccine Boosts Survival Rates in Advanced Liver Cancer Patients, Mongolian Study Finds
Patients with advanced, inoperable hepatocellular carcinoma (HCC) may highly benefit from Immunitor‘s new oral immunotherapeutic vaccine, Hepko-V5 (hepcortespenlisimut-L), according to results of a Phase 2 trial.
FDA Approves Stivarga as Treatment for Common Form of Liver Cancer
The U.S. Food and Drug Administration (FDA) approved the use of Stivarga (regorafinib) for the treatment of patients with hepatocellular carcinoma (HCC), a form of…
Radiation-delivering Microspheres Fight Liver Cancer as Well as Chemo, Clinical Trial Indicates
Radiation-delivering microspheres developed by Sirtex are as effective as Nexavar (sorafenib) chemotherapy against a liver cancer known as hepatocellular carcinoma (HCC), according to a Phase 3…
NeuroVive’s NV556 Inhibits Liver Tumor Growth in Mice, Study Indicates
NV556 inhibited tumor growth in mice with a liver disease known as non-alcoholic steatohepatitis, or NASH, according to a study by its maker, NeuroVive Pharmaceutical AB.
Bozitinib Suppresses Liver Tumor Growth in Lab Setting, Study Shows
Bozitinib (CBT-101) suppresses the growth of human liver tumors in a laboratory environment, according to its maker, CBT Pharmaceuticals. The oral therapy works by…
New Approach to Drug Discovery Finds Veterinary Pill Helps Mice Fight Liver Cancer
A relative of a veterinary de-worming pill, in combination with the standard treatment Nexavar (sorafenib), was found to halt the growth of hepatocellular cancer (HCC) in laboratory…
Immune Cells That Produce a Certain Protein Could Be Used to Fight Liver Cancer, Study Reports
A subset of stem cell-derived immune cells, known as iPS-ML, stopped tumor progression and improved survival of mice with liver cancer, a Japanese study showed.
TGF-beta Protein Fosters Conversion of Normal Liver Cells to Cancerous, Study Suggests
The transforming growth factor-beta (TGF-beta) protein promotes the conversion of normal liver cells to cancerous cells, a study indicates. It also regulates liver cancer cells’ ability to…
Recent Posts
- Agrimonolide shows benefits in cholestasis mouse model
- The health risks of soda, including liver damage, are increasingly clear
- Dosing begins in trial of drug combo for severe fatty liver disease
- Liver Foundation honors family who turned diagnosis into giving
- Oregon gets $7.5M US grant to treat HCV with telehealth, peer support